AP
ISEE

AlpInvest Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

AlpInvest Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-111,519
Closed -$4.52M – 35
2015
Q3 		$4.52M Hold
111,519
– – 8.9% 4
2015
Q2 		$5.81M Buy
111,519
+74,019
+197% +$3.68M 7.35% 4
2015
Q1 		$1.75M Sell
37,500
-28,136
-43% -$1.46M 3.27% 7
2014
Q4 		$2.94M Sell
65,636
-16,410
-20% -$689K 7.3% 2
2014
Q3 		$3.19M Hold
82,046
– – 9.96% 2
2014
Q2 		$3.47M Buy
+82,046
New +$3.01M 12.36% 3

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlpInvest Partners's ISEE Position: Q4 2015 in Review

AlpInvest Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2015, closing a stake of 111,519 shares — an estimated $4.52M sold.

AlpInvest Partners first reported a position in ISEE in Q2 2014 and held it in 6 quarters. The position peaked at $5.81M in Q2 2015. 152 funds tracked by Wall St. Rank hold ISEE as of Q4 2015.

  • AlpInvest Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • AlpInvest Partners sold 111,519 IVERIC bio, Inc. Common Stock shares in Q4 2015, an estimated $4.52M.
  • AlpInvest Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
  • AlpInvest Partners's IVERIC bio, Inc. Common Stock position peaked at $5.81M in Q2 2015.
  • 152 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2015.

Based on AlpInvest Partners's 13F filing for Q4 2015, filed 12 Feb 2016.